Adele Gautier: Breast Cancer Foundation researcher discusses Pharmac consideration of switch to Herzuma

Changes are on the cards for some breast cancer patients.

Pharmac is consulting on a drug switch proposal to replace the current expired one.

Herzuma is said to be more safe and cost effective, but at what there are concerns about whether all patients will be suited to it.

Breast Cancer Foundation's Research and Strategics Manager, Adele Gautier, joined Kate Hawkesby.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.